Montenegro vs Slovenia: Lung cancer death rates
Montenegro
14.26 deaths per 100,000 people
in 2019
Slovenia
15.74 deaths per 100,000 people
in 2023
Montenegro rank
21st
Slovenia rank
18th
Lung cancer death rates over time
- Montenegro
- Slovenia
How they compare
Slovenia currently reports 15.74 deaths per 100,000 people against 14.26 deaths per 100,000 people in Montenegro, a difference of 1.48 deaths per 100,000 people.
That makes Slovenia's figure about 1.1 times Montenegro's.
The two have swapped places 3 times across 12 shared years of data; in 2000 it was Montenegro ahead.
Montenegro ranks 21st and Slovenia ranks 18th of 111 countries.
Across the 2 decades both report, Montenegro averaged higher in 1 and Slovenia in 1.
Head to head by decade
| Decade | Montenegro | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.04 deaths per 100,000 people | 13.56 deaths per 100,000 people | 1.48 deaths per 100,000 people | Montenegro |
| 2010s | 14.73 deaths per 100,000 people | 18.22 deaths per 100,000 people | 3.49 deaths per 100,000 people | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher lung cancer death rates, Montenegro or Slovenia?
- Slovenia, at 15.74 deaths per 100,000 people against 14.26 deaths per 100,000 people in Montenegro as of 2023.
- What is the difference in lung cancer death rates between Montenegro and Slovenia?
- 1.48 deaths per 100,000 people, with Slovenia ahead.
- How many years of comparable data are there for Montenegro and Slovenia?
- 12 years are reported by both, from 2000 to 2019.
- How do Montenegro and Slovenia rank globally for lung cancer death rates?
- Montenegro ranks 21st and Slovenia ranks 18th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Lung cancer death rates. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from trachea, bronchus, lung cancers in females in those aged all ages per 100,000 people.